General Information of DTT (ID: TTFOUV4)

DTT Name BCL-2 messenger RNA (BCL2 mRNA) DTT Info
Gene Name BCL2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PNT-2258 DMUVON0 Diffuse large B-cell lymphoma 2A81 Phase 2 [1]
Beclanorsen DMXVRI0 leukaemia 2A60-2B33 Phase 1/2 [2]
BP1002 DMI826O Haematopoietic/lymphoid cancer 2B33.5 Phase 1 [3]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BP-100-1.02 DMGEYFB Lymphoma 2A80-2A86 Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of ProNAi.
2 Combination of novel imidazopyridazine mps-1 kinase inhibitors and bcl-2 family protein inhibitors. ACS Med Chem Lett. 2014 Jul 30;6(1):7-8.
3 Clinical pipeline report, company report or official report of Bio-Path Holdings.
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2844).